Evidence map›Paper›PMID 36568782›Full record

ArticleFrontiers in public health2022

Detection of SARS-CoV-2 infection clusters: The useful combination of spatiotemporal clustering and genomic analyses.

Yangji Choi, Anaïs Ladoy, David De Ridder, Damien Jacot, Séverine Vuilleumier, Claire Bertelli, Idris Guessous, Trestan Pillonel, Stéphane Joost, Gilbert Greub

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yangji ChoiInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Anaïs LadoyLaboratory of Geographic Information Systems (LASIG), School of Architecture, Civil and Environmental Engineering (ENAC), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
David De RidderLaboratory of Geographic Information Systems (LASIG), School of Architecture, Civil and Environmental Engineering (ENAC), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Damien JacotInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Séverine VuilleumierLa Source School of Nursing, University of Applied Sciences and Arts Western Switzerland (HES-SO), Lausanne, Switzerland.
Claire BertelliInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Idris GuessousGroup of Geographic Information Research and Analysis in Population Health (GIRAPH), Geneva, Switzerland.
Trestan PillonelInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Stéphane JoostLaboratory of Geographic Information Systems (LASIG), School of Architecture, Civil and Environmental Engineering (ENAC), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Gilbert GreubInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
University of Lausanne · CHÉcole Polytechnique Fédérale de Lausanne · CHHES-SO University of Applied Sciences and Arts Western Switzerland · CHUniversity Hospital of Geneva · CHUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The need for effective public health surveillance systems to track virus spread for targeted interventions was highlighted during the COVID-19 pandemic. It spurred an interest in the use of spatiotemporal clustering and genomic analyses to identify high-risk areas and track the spread of the SARS-CoV-2 virus. However, these two approaches are rarely combined in surveillance systems to complement each one's limitations; spatiotemporal clustering approaches usually consider only one source of virus transmission (i.e., the residential setting) to detect case clusters, while genomic studies require significant resources and processing time that can delay decision-making. Here, we clarify the differences and possible synergies of these two approaches in the context of infectious disease surveillance systems by investigating to what extent geographically-defined clusters are confirmed as transmission clusters based on genome sequences, and how genomic-based analyses can improve the epidemiological investigations associated with spatiotemporal cluster detection. Methods: For this purpose, we sequenced the SARS-CoV-2 genomes of 172 cases that were part of a collection of spatiotemporal clusters found in a Swiss state (Vaud) during the first epidemic wave. We subsequently examined intra-cluster genetic similarities and spatiotemporal distributions across virus genotypes. Results: Our results suggest that the congruence between the two approaches might depend on geographic features of the area (rural/urban) and epidemic context (e.g., lockdown). We also identified two potential superspreading events that started from cases in the main urban area of the state, leading to smaller spreading events in neighboring regions, as well as a large spreading in a geographically-isolated area. These superspreading events were characterized by specific mutations assumed to originate from Mulhouse and Milan, respectively. Our analyses propose synergistic benefits of using two complementary approaches in public health surveillance, saving resources and improving surveillance efficiency.

Indexed as

COVID-19Cluster AnalysisCommunicable Disease ControlGenomicsHumansPandemicsSARS-CoV-2COVID-19epidemiologygenetic similaritiesgenomicspublic health surveillanceSARS-CoV-2spatiotemporal clustersuperspreading

Identifiers

PMID36568782
PMCPMC9771593
OpenAlexW4311161237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.